• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肾细胞癌骨转移：积极手术和抗血管生成治疗4年后

Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti-angiogenic therapy.

作者信息

Nefiss Mouadh, Abid Hichem, Gharbi Mohamed Amine, Bouzidi Ramzi, Teborbi Anis

机构信息

Department of Orthopaedic Surgery Mongi Slim University Hospital La Marsa Tunisia.

Tunis El Manar University Tunis Tunisia.

出版信息

Clin Case Rep. 2022 Nov 15;10(11):e6599. doi: 10.1002/ccr3.6599. eCollection 2022 Nov.

DOI:10.1002/ccr3.6599
PMID:36408090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9666916/
Abstract

Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision-making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectomy and surgery of a revealing clavicular metastasis.

摘要

在改善总生存期（OS）的靶向治疗时代之后，肾细胞癌（RCC）骨转移的管理发生了显著变化。手术决策仍然是一个有争议的话题。我们报告一例RCC盆腔骨转移病例，该病例发生在肾切除术后2个月以及锁骨转移灶切除术后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c58/9666916/9c015dae2f5d/CCR3-10-e6599-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c58/9666916/c2cf941ebeb2/CCR3-10-e6599-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c58/9666916/5e5f5dccee23/CCR3-10-e6599-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c58/9666916/9c015dae2f5d/CCR3-10-e6599-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c58/9666916/c2cf941ebeb2/CCR3-10-e6599-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c58/9666916/5e5f5dccee23/CCR3-10-e6599-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c58/9666916/9c015dae2f5d/CCR3-10-e6599-g004.jpg

相似文献

1
Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti-angiogenic therapy.肾细胞癌骨转移：积极手术和抗血管生成治疗4年后
Clin Case Rep. 2022 Nov 15;10(11):e6599. doi: 10.1002/ccr3.6599. eCollection 2022 Nov.
2
Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy.靶向治疗时代转移性肾细胞癌骨转移姑息性手术的疗效。
Eur J Surg Oncol. 2023 May;49(5):928-933. doi: 10.1016/j.ejso.2022.11.094. Epub 2022 Nov 25.
3
Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapy.分子靶向治疗和/或免疫治疗背景下肾细胞癌脑转移切除的生存获益。
Curr Probl Cancer. 2022 Apr;46(2):100805. doi: 10.1016/j.currproblcancer.2021.100805. Epub 2021 Nov 18.
4
[RENAL CELL CARCINOMA METASTASIS TO BLADDER DURING MOLECULAR TARGETED THERAPY WITH PAZOPANIB: REPORT OF TWO CASES].[帕唑帕尼分子靶向治疗期间肾细胞癌转移至膀胱：2例报告]
Nihon Hinyokika Gakkai Zasshi. 2020;111(2):58-61. doi: 10.5980/jpnjurol.111.58.
5
Lost in time pulmonary metastases of renal cell carcinoma: complete surgical resection of metachronous metastases, 18 and 15 years after nephrectomy.肾癌肺转移伴时间迁延：18 年和 15 年后行根治性切除术治疗肾切除术后异时性转移
J Thorac Dis. 2012 Nov;4 Suppl 1(Suppl 1):69-73. doi: 10.3978/j.issn.2072-1439.2012.s003.
6
Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).肾细胞癌（RCC）非典型转移的外科治疗。
BJU Int. 2012 Dec;110(11 Pt B):E559-63. doi: 10.1111/j.1464-410X.2012.11271.x. Epub 2012 May 28.
7
Molecular-targeted Therapy and Surgery May Prolong Survival of Renal Cell Carcinoma Patients with Bone Metastasis: A Multi-institutional Retrospective Study in Japan.分子靶向治疗与手术可能延长肾细胞癌骨转移患者的生存期：日本一项多机构回顾性研究
Anticancer Res. 2016 Oct;36(10):5531-5536. doi: 10.21873/anticanres.11136.
8
Pathological clavicular fracture as first presentation of renal cell carcinoma: a case report and literature review.病理性锁骨骨折作为肾细胞癌的首发表现：一例病例报告及文献综述
Cancer Biol Med. 2015 Dec;12(4):409-12. doi: 10.7497/j.issn.2095-3941.2015.0033.
9
Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.伴有逆行静脉侵犯及21号染色体获得的嫌色性肾细胞癌：侵袭性临床行为的潜在预兆
Int J Surg Pathol. 2018 Sep;26(6):536-541. doi: 10.1177/1066896918763948. Epub 2018 Mar 21.
10
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.转移性肾细胞癌在靶向治疗时代中的作用。
Curr Urol Rep. 2013 Feb;14(1):19-25. doi: 10.1007/s11934-012-0293-6.

引用本文的文献

1
Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma.转移性肾癌：转移部位重要吗？迈向转移性肾细胞癌的个性化治疗。
Biomedicines. 2024 May 16;12(5):1111. doi: 10.3390/biomedicines12051111.
2
Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review.治疗肾细胞癌不同转移部位的选择：综述。
Medicine (Baltimore). 2024 May 24;103(21):e38268. doi: 10.1097/MD.0000000000038268.

本文引用的文献

1
The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma.减瘤性肾切除术在转移性肾细胞癌中的当前作用。
Indian J Urol. 2021 Jan-Mar;37(1):13-19. doi: 10.4103/iju.IJU_293_20. Epub 2021 Jan 1.
2
Metastatic Renal Cell Carcinoma to the Spine and the Extremities: Evaluation, Diagnosis, and Treatment.脊柱和四肢转移性肾细胞癌：评估、诊断与治疗
JBJS Rev. 2019 Sep;7(9):e7. doi: 10.2106/JBJS.RVW.19.00002.
3
Treating patients with renal cell carcinoma and bone metastases.治疗患有肾细胞癌和骨转移的患者。
Expert Rev Anticancer Ther. 2018 Nov;18(11):1135-1143. doi: 10.1080/14737140.2018.1520097. Epub 2018 Sep 13.
4
The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016.细胞减灭性肾切除术的作用：欧洲泌尿外科学会 2016 年推荐
Eur Urol. 2016 Dec;70(6):901-905. doi: 10.1016/j.eururo.2016.07.005. Epub 2016 Jul 18.
5
Bone Metastasis from Renal Cell Carcinoma.肾细胞癌骨转移
Int J Mol Sci. 2016 Jun 22;17(6):987. doi: 10.3390/ijms17060987.
6
[Medical therapies for locally advanced/metastatic kidney cancer].[局部晚期/转移性肾癌的医学治疗]
Presse Med. 2015 Feb;44(2):135-43. doi: 10.1016/j.lpm.2014.07.020. Epub 2014 Dec 18.
7
Renal cell carcinoma bone metastases: clinical advances.肾细胞癌骨转移：临床进展。
Ther Adv Med Oncol. 2010 Mar;2(2):75-83. doi: 10.1177/1758834009358417.
8
Bone metastases from renal cell carcinoma: patient survival after surgical treatment.肾癌骨转移：手术治疗后的患者生存情况。
BMC Musculoskelet Disord. 2010 Jul 3;11:145. doi: 10.1186/1471-2474-11-145.
9
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.舒尼替尼与干扰素α治疗转移性肾细胞癌的对比研究
N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044.
10
Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment.肾细胞癌的孤立性骨转移：手术治疗的意义
Clin Orthop Relat Res. 2005 Feb(431):187-92. doi: 10.1097/01.blo.0000149820.65137.b4.